UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:UTI - US9139151040 - Common Stock
26.29 USD
-0.27 (-1.02%)
27.01 USD
+0.72 (+2.74%)
We assign a fundamental rating of 5 out of 10 to UTI. UTI was compared to 77 industry peers in the Diversified Consumer Services industry. UTI has an excellent profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, UTI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year UTI was profitable.
UTI had a positive operating cash flow in the past year.
Each year in the past 5 years UTI has been profitable.
Each year in the past 5 years UTI had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 7.63%, UTI is doing good in the industry, outperforming 72.73% of the companies in the same industry.
UTI's Return On Equity of 19.21% is amongst the best of the industry. UTI outperforms 83.12% of its industry peers.
UTI's Return On Invested Capital of 10.46% is amongst the best of the industry. UTI outperforms 83.12% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UTI is below the industry average of 10.17%.
The 3 year average ROIC (7.27%) for UTI is below the current ROIC(10.46%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROIC | 10.46% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
1.3 Margins
With a decent Profit Margin value of 7.54%, UTI is doing good in the industry, outperforming 66.23% of the companies in the same industry.
UTI's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 9.99%, UTI is doing good in the industry, outperforming 64.94% of the companies in the same industry.
UTI's Operating Margin has improved in the last couple of years.
UTI has a Gross Margin of 49.68%. This is comparable to the rest of the industry: UTI outperforms 54.55% of its industry peers.
In the last couple of years the Gross Margin of UTI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% |
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UTI is creating some value.
Compared to 1 year ago, UTI has more shares outstanding
Compared to 5 years ago, UTI has more shares outstanding
The debt/assets ratio for UTI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.27 indicates that UTI is not in any danger for bankruptcy at the moment.
UTI has a better Altman-Z score (3.27) than 79.22% of its industry peers.
The Debt to FCF ratio of UTI is 1.57, which is an excellent value as it means it would take UTI, only 1.57 years of fcf income to pay off all of its debts.
UTI has a better Debt to FCF ratio (1.57) than 83.12% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that UTI is not too dependend on debt financing.
UTI has a Debt to Equity ratio (0.26) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Altman-Z | 3.27 |
ROIC/WACC1.23
WACC8.48%
2.3 Liquidity
UTI has a Current Ratio of 1.07. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.07, UTI is in line with its industry, outperforming 46.75% of the companies in the same industry.
A Quick Ratio of 1.07 indicates that UTI should not have too much problems paying its short term obligations.
UTI has a Quick ratio (1.07) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.05% over the past year.
UTI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 65.96% yearly.
UTI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.05%.
The Revenue has been growing by 22.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
3.2 Future
The Earnings Per Share is expected to decrease by -11.46% on average over the next years. This is quite bad
Based on estimates for the next years, UTI will show a quite strong growth in Revenue. The Revenue will grow by 9.04% on average per year.
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 23.06, UTI is valued on the expensive side.
UTI's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.39, UTI is valued at the same level.
With a Price/Forward Earnings ratio of 32.90, UTI can be considered very expensive at the moment.
UTI's Price/Forward Earnings ratio is in line with the industry average.
UTI is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.06 | ||
| Fwd PE | 32.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTI is valued a bit cheaper than 61.04% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UTI is valued a bit cheaper than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.85 | ||
| EV/EBITDA | 11.23 |
4.3 Compensation for Growth
UTI has a very decent profitability rating, which may justify a higher PE ratio.
UTI's earnings are expected to decrease with -11.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.35
EPS Next 2Y-11.46%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for UTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
26.29
-0.27 (-1.02%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.95%
Inst Owner Change-1.21%
Ins Owners2.24%
Ins Owner Change5.07%
Market Cap1.43B
Revenue(TTM)835.62M
Net Income(TTM)63.02M
Analysts81.82
Price Target38.18 (45.23%)
Short Float %4.02%
Short Ratio2.77
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.09%
Min EPS beat(2)28.91%
Max EPS beat(2)69.26%
EPS beat(4)4
Avg EPS beat(4)73.64%
Min EPS beat(4)28.91%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)75.72%
EPS beat(12)10
Avg EPS beat(12)77.26%
EPS beat(16)14
Avg EPS beat(16)214.91%
Revenue beat(2)2
Avg Revenue beat(2)0.81%
Min Revenue beat(2)0.47%
Max Revenue beat(2)1.15%
Revenue beat(4)4
Avg Revenue beat(4)2.24%
Min Revenue beat(4)0.47%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.25%
Revenue beat(12)12
Avg Revenue beat(12)3.17%
Revenue beat(16)15
Avg Revenue beat(16)3.41%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-43.74%
EPS NQ rev (3m)-44.7%
EPS NY rev (1m)-14.26%
EPS NY rev (3m)-20.2%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.06 | ||
| Fwd PE | 32.9 | ||
| P/S | 1.71 | ||
| P/FCF | 25.85 | ||
| P/OCF | 14.7 | ||
| P/B | 4.36 | ||
| P/tB | 5.07 | ||
| EV/EBITDA | 11.23 |
EPS(TTM)1.14
EY4.34%
EPS(NY)0.8
Fwd EY3.04%
FCF(TTM)1.02
FCFY3.87%
OCF(TTM)1.79
OCFY6.8%
SpS15.35
BVpS6.03
TBVpS5.19
PEG (NY)N/A
PEG (5Y)0.35
Graham Number12.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.63% | ||
| ROE | 19.21% | ||
| ROCE | 13.99% | ||
| ROIC | 10.46% | ||
| ROICexc | 14.6% | ||
| ROICexgc | 16.35% | ||
| OM | 9.99% | ||
| PM (TTM) | 7.54% | ||
| GM | 49.68% | ||
| FCFM | 6.62% |
ROA(3y)4.45%
ROA(5y)3.5%
ROE(3y)11.95%
ROE(5y)9.34%
ROIC(3y)7.27%
ROIC(5y)5.89%
ROICexc(3y)10.21%
ROICexc(5y)8.25%
ROICexgc(3y)11.54%
ROICexgc(5y)9.21%
ROCE(3y)9.72%
ROCE(5y)7.88%
ROICexgc growth 3Y34.26%
ROICexgc growth 5YN/A
ROICexc growth 3Y33.76%
ROICexc growth 5YN/A
OM growth 3Y17.03%
OM growth 5YN/A
PM growth 3Y35.13%
PM growth 5Y53.06%
GM growth 3Y-13.36%
GM growth 5Y-8.21%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.57 | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 127.37% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 14.13 | ||
| Cash Conversion | 83.6% | ||
| Profit Quality | 87.84% | ||
| Current Ratio | 1.07 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 3.27 |
F-Score6
WACC8.48%
ROIC/WACC1.23
Cap/Depr(3y)145.01%
Cap/Depr(5y)268.95%
Cap/Sales(3y)5.89%
Cap/Sales(5y)11.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3Y3.11%
EPS 5Y65.96%
EPS Q2Q%0%
EPS Next Y-29.91%
EPS Next 2Y-11.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.05%
Revenue growth 3Y25.89%
Revenue growth 5Y22.67%
Sales Q2Q%13.28%
Revenue Next Year9.06%
Revenue Next 2Y9.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.41%
EBIT growth 3Y47.33%
EBIT growth 5YN/A
EBIT Next Year47.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.14%
FCF growth 3YN/A
FCF growth 5Y99.08%
OCF growth 1Y13.31%
OCF growth 3Y28.35%
OCF growth 5Y54.57%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 5 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 3 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Overvalued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 23.06 and the Price/Book (PB) ratio is 4.36.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to decline by -29.91% in the next year.